Druggio Logo

Druggio

Kissei Pharmaceutical

Kissei Pharmaceutical is a Japan-based company founded in 1946, with a focus on research and development of pharmaceuticals. The company specializes in drugs for conditions such as urological disorders, ophthalmological diseases, and nephrological diseases. Some of their key drugs include Tamsulosin hydrochloride for the treatment of benign prostatic hyperplasia, and Dorzolamide hydrochloride for glaucoma. Their commitment to scientific research and development has made them a prominent player in the pharmaceutical industry.

Kissei Pharmaceutical's Drugs

Savene

Approval date

2014/1/17

Urief, Silodosin

Approval date

2006/1/23

Glufast

Approval date

2004/1/29